Advertisement

Topics

Aprea AB Company Profile

15:08 EDT 20th June 2019 | BioPortfolio

Aprea AB is a Swedish biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead program, APR-246, is a first-in-class small molecule drug candidate in clinical development. Aprea's main shareholder is KDev Investments AB, an investment vehicle owned by Karolinska Development AB (Nasdaq Stockholm: KDEV) and Rosetta Capital Ltd. Other shareholders include Östersjöstiftelsen, Praktikerinvest and KCIF Co-Investment Fund KB. For more information, please visit www.aprea.com.


News Articles [12 Associated News Articles listed on BioPortfolio]

Eyal Attar Leaves Agios for Chief Medical Officer Role at Aprea

Aprea Therapeutics has appointed Eyal Attar senior vice president and chief medical officer. Attar joins Aprea from Agios Pharmaceuticals, where he was senior medical director and IDH hematology medic...

Aprea Therapeutics Closes €50M Financing https://www.prnewswire.com/news-releases/aprea-therapeutics-closes-eur-50-million-financing-300758107.html …

Aprea Therapeutics Closes €50M Financing https://www.prnewswire.com/news-releases/aprea-therapeutics-closes-eur-50-million-financing-300758107.html …

Biopharmaceutical firm Aprea Therapeutics raises €50m in financing

The Series C financing round was led by the Redmile Group, with participation by new investor Rock Springs Capital and existing investors 5AM Ventures, Versant Ventures, HealthCap, Sectoral The post ...

Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics appoints a new Chief Medical Officer

STOCKHOLM, March 25, 2019. Karolinska Development's portfolio company Aprea Therapeutics announces today that Dr. Eyal C. Attar has been appointed to a position as Senior Vice President and Chief ...

First-in-Class Cancer Drug Gets €50M Boost

The biopharmaceutical company Aprea Therapeutics has raised €50M to fund a Phase III trial of its first-in-class cancer drug candidate, which kills tumor cells by restoring the function of a key ant...

Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea presents promising results with APR-246 in combination with immuno-oncology agents

STOCKHOLM, April 3, 2019. Karolinska Development's portfolio company Aprea today presents results from studies with APR-246 in combination with immune checkpoint blockade. The results show that AP...

First-in-Class Cancer Drug Gets Funding Boost

The biopharmaceutical company Aprea Therapeutics has raised €50M to fund a Phase III trial of its first-in-class cancer drug candidate, which kills tumor cells by restoring the function of a key ant...

Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 246

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Aprea AB

Aprea AB is a Swedish biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead pro...

Karolinska Development and Aprea

Karolinska Development manages one of the largest portfolios of life science companies in Europe. Using a unique, highly cost efficient business model, the management team guides the commercializa...

More Information about "Aprea AB" on BioPortfolio

We have published hundreds of Aprea AB news stories on BioPortfolio along with dozens of Aprea AB Clinical Trials and PubMed Articles about Aprea AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aprea AB Companies in our database. You can also find out about relevant Aprea AB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record